News

Stay informed on the forefront of innovation in the field of Cell & Gene Therapies and Nucleic Acids with Anemocyte, the leading Italian company in plasmid DNA and mRNA development and manufacturing.

Our products and services are essential components for the research, development and production of new generation medicines as for example vaccines, immuno-oncology therapies, and protein replacement treatments.

Discover our latest initiatives, technology advancements, expansion plans, and our ongoing commitment to research and development of cutting-edge solutions for Cell & Gene Therapies and Nucleic Acids.

Advanced Therapies Week 2025
advanced therapies event

Advanced Therapies Week 2025

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Advanced Therapies Week 2025 in Dallas, TX

read more
1200 900 Anemocyte.com
The Future of Advanced Therapies: Emerging Innovations in Cell and Gene Therapies
plasmid and mrna manufacturing

The Future of Advanced Therapies: Emerging Innovations in Cell and Gene Therapies

Advanced therapies, particularly cell and gene therapies, are ushering in a new era of personalized medicine, offering hope for patients with previously untreatable diseases.

read more
1200 900 Anemocyte.com
Anemocyte Pioneers Safer Horizons in Gene Therapy with Non-Viral Genetic Modification Techniques
plasmid and mrna manufacturing

Anemocyte Pioneers Safer Horizons in Gene Therapy with Non-Viral Genetic Modification Techniques

What is the perfect recipe that delivers the maximum result?

read more
1200 900 Anemocyte.com
The Perfect Recipe: Driving Sustainability, Flexibility, Quality, and Innovation in Cell and Gene Therapy
quality assurance plasmid dna

The Perfect Recipe: Driving Sustainability, Flexibility, Quality, and Innovation in Cell and Gene Therapy

What is the perfect recipe that delivers the maximum result?

read more
2192 2192 Anemocyte.com
Our DNA: A Culture of Teamwork, Safety, and Strategic Growth
plasmid dna sequence

Our DNA: A Culture of Teamwork, Safety, and Strategic Growth

Working in a Biotech Manufacturing Organization means joining a team of talented professionals focused on innovation, continuous growth, and a shared mission to improve lives.

read more
2560 1260 Anemocyte.com
12th International mRNA Health Conference
international mrna health conference

12th International mRNA Health Conference

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to 12th International mRNA Health Conference 2024 in Boston, MA

read more
2400 1800 Anemocyte.com
1st Annual Meeting AMM ASCENT
alliance for mrna medicines

1st Annual Meeting AMM ASCENT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to 1st Annual Meeting AMM ASCENT in Boston, MA

read more
2400 1800 Anemocyte.com
Anemocyte Plasmid DNA Offering: Comprehensive Solutions from R&D to GMP
plasmid dna manufacturing news anemocyte

Anemocyte Plasmid DNA Offering: Comprehensive Solutions from R&D to GMP

Anemocyte offers plasmid DNA (pDNA) manufacturing covering R&D, High Quality and GMP needs providing solutions that support every stage of therapy development while ensuring rigorous quality and traceability.

read more
1201 900 Anemocyte.com
ESGCT Rome
european society gene therapy logo

ESGCT Rome

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2024 in Rome, Italy

read more
1200 900 Anemocyte.com
Quality Assurance in Plasmid DNA Manufacturing
plasmid dna manufacturing news anemocyte

Quality Assurance in Plasmid DNA Manufacturing

Quality assurance (QA) is crucial in the manufacturing of plasmid DNA (pDNA), a key component in gene therapy, vaccine development, genome editing, and synthetic biology.

read more
1201 900 Anemocyte.com
BioJapan 2024
bio japan world business forum logo

BioJapan 2024

BIO International Convention 9-11 october 2024 | Yokohama, Japan.

read more
2400 1800 Anemocyte.com
Meeting on the Mesa
cell gene meeting

Meeting on the Mesa

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting on the Mesa in Phoenix, Arizona

read more
2400 1800 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961